Second cancer is the leading cause of death in lymphoma survivors, with lung cancer representing the most common solid tumor. Limited information exists about the treatment and prognosis of second lung cancer following lymphoma. Herein, we evaluated the outcome and prognostic factors of Lung Cancer in Lymphoma Survivors (the LuCiLyS study) to improve the patient selection for lung cancer treatment.
Prognostic factors of lung cancer in lymphoma survivors (the LuCiLyS study) / A. Fiorelli, A. D'Andrilli, A. Carlucci, G. Vicidomini, D. Loizzi, N.P. Ardò, R.D. Marasco, L. Ventura, L. Ampollini, P. Carbognani, G. Bocchialini, F. Lococo, M. Paci, T.S. Di Stefano, F. Ardissone, M. Gagliasso, P. Mendogni, L. Rosso, A. Mazzucco, C. Vanni, B.T. Marinucci, R. Potenza, A. Matricardi, M. Ragusa, V. Tassi, M. Anile, C. Poggi, N. Serra, A. Sica, M. Nosotti, F. Sollitto, F. Venuta, E.A. Rendina, F. Puma, M. Santini. - In: TRANSLATIONAL LUNG CANCER RESEARCH. - ISSN 2218-6751. - 9:1(2020 Feb), pp. 90-102. [10.21037/tlcr.2019.12.28]
Prognostic factors of lung cancer in lymphoma survivors (the LuCiLyS study)
L. Rosso;A. Mazzucco;M. Nosotti;
2020
Abstract
Second cancer is the leading cause of death in lymphoma survivors, with lung cancer representing the most common solid tumor. Limited information exists about the treatment and prognosis of second lung cancer following lymphoma. Herein, we evaluated the outcome and prognostic factors of Lung Cancer in Lymphoma Survivors (the LuCiLyS study) to improve the patient selection for lung cancer treatment.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Transl Lung Cancer Res.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
790.82 kB
Formato
Adobe PDF
|
790.82 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
